Ventyx Biosciences, Inc. (VTYX) Financials

VTYX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 277.7 million 33.8 million
2023-09-30 321.7 million 38.1 million
2023-06-30 348.8 million 21.0 million
2023-03-31 389.2 million 17.6 million

VTYX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -51.9 million 6.1 million
2023-09-30 -34.7 million 8.0 million
2023-06-30 -49.5 million 7.9 million
2023-03-31 -31.0 million 6.6 million

VTYX Net Income

No data available :(

VTYX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 252.2 million - 12.5 million
2023-09-30 300.8 million - 12.3 million
2023-06-30 332.3 million - 1.4 million
2023-03-31 376.9 million - 1.5 million

VTYX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 59.1 million
2023-09-30 58.9 million
2023-06-30 58.6 million
2023-03-31 57.6 million

VTYX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 211000 40.3 million 8.3 million -903000
2023-09-30 48000 49.8 million 8.2 million -
2023-06-30 195000 48.6 million 8.6 million -
2023-03-31 60000 35.4 million 7.1 million -

VTYX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 403000
2023-09-30 - 265000
2023-06-30 - 139000
2023-03-31 - 134000

VTYX

Price: $4.91

52 week price:
1.87
40.58

Earnings Per Share: -3.30 USD

P/E Ratio: -0.70

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 2.2 million

Market Capitalization: 345.1 million

Links: